Yüklüyor…
Dissecting the Immunological Profiles in NSD3-Amplified LUSC through Integrative Multi-Scale Analyses
SIMPLE SUMMARY: Although cancer immunotherapy has become a “game changer” in treating LUSC patients, challenges still prevail due to the heterogeneous response and insufficient predictive biomarkers. Recently, NSD3, a neighbor gene of FGFR1, was identified as a key genetic driver of LUSC tumorigenes...
Asıl Yazarlar: | , , , , , , , |
---|---|
Materyal Türü: | Online Makale Metin |
Dil: | English |
Baskı/Yayın Bilgisi: |
MDPI
2022
|
Konular: | |
Online Erişim: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599511/ https://www.ncbi.nlm.nih.gov/pubmed/36291782 http://dx.doi.org/10.3390/cancers14204997 |